Assessment of the Burden of Small Intestinal Bacterial Overgrowth (SIBO) in Patients After Oesophagogastric (OG) Cancer Resection - Takeaways - MDSpire

Assessment of the Burden of Small Intestinal Bacterial Overgrowth (SIBO) in Patients After Oesophagogastric (OG) Cancer Resection

  • By

  • K.-V. Savva

  • L. Hage

  • I. Belluomo

  • P. Gummet

  • P. R. Boshier

  • C. J. Peters

  • October 20, 2021

  • 0 min

Share

  • 1

    SIBO is prevalent in patients after oesophagogastric cancer resection, with a high incidence of 73.5% in the studied cohort.

  • 2

    The study included 45 patients who had undergone oesophagectomy or gastrectomy, all at least one year post-surgery.

  • 3

    Digestive symptom scores did not significantly differ between SIBO-positive and SIBO-negative patients, indicating nonspecific symptoms.

  • 4

    The study suggests that SIBO may be underdiagnosed due to the limitations of glucose hydrogen breath tests.

  • 5

    There is a need for improved guidelines for the assessment and treatment of SIBO in patients after oesophagogastric cancer surgery.

Original Source(s)

Assessment of the Burden of Small Intestinal Bacterial Overgrowth (SIBO) in Patients After Oesophagogastric (OG) Cancer Resection

  • by K.-V. Savva, L. Hage, I. Belluomo, P. Gummet, P. R. Boshier, C. J. Peters

  • October 20, 2021

Related Content

eNCApsulate: neural cellular automata for precision diagnosis on capsule endoscopes

Quality of life in benign colorectal disease—a review of the assessment with the Gastrointestinal Quality of Life Index (GIQLI)

Design of a force-measuring setup for colorectal compression anastomosis and first ex-vivo results